DK0759929T3 - Oxidation af steroider, der har allylgrupper - Google Patents
Oxidation af steroider, der har allylgrupperInfo
- Publication number
- DK0759929T3 DK0759929T3 DK95920434T DK95920434T DK0759929T3 DK 0759929 T3 DK0759929 T3 DK 0759929T3 DK 95920434 T DK95920434 T DK 95920434T DK 95920434 T DK95920434 T DK 95920434T DK 0759929 T3 DK0759929 T3 DK 0759929T3
- Authority
- DK
- Denmark
- Prior art keywords
- steroids
- oxidation
- allyl groups
- allylic
- delta
- Prior art date
Links
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 title 1
- 230000003647 oxidation Effects 0.000 title 1
- 238000007254 oxidation reaction Methods 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 125000000746 allylic group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 abstract 1
- 150000001336 alkenes Chemical class 0.000 abstract 1
- XXROGKLTLUQVRX-UHFFFAOYSA-N allyl alcohol Chemical group OCC=C XXROGKLTLUQVRX-UHFFFAOYSA-N 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 229910052707 ruthenium Inorganic materials 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
- C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
- C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
- B01J23/46—Ruthenium, rhodium, osmium or iridium
- B01J23/462—Ruthenium
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
- B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
- B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
- B01J23/56—Platinum group metals
- B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
- B01J23/652—Chromium, molybdenum or tungsten
- B01J23/6527—Tungsten
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24593594A | 1994-05-19 | 1994-05-19 | |
PCT/US1995/006004 WO1995032215A1 (en) | 1994-05-19 | 1995-05-15 | Oxidation of steroids having allylic groups |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0759929T3 true DK0759929T3 (da) | 2000-11-13 |
Family
ID=22928693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK95920434T DK0759929T3 (da) | 1994-05-19 | 1995-05-15 | Oxidation af steroider, der har allylgrupper |
Country Status (23)
Country | Link |
---|---|
US (1) | US6369247B1 (da) |
EP (1) | EP0759929B1 (da) |
JP (1) | JPH10500682A (da) |
KR (1) | KR970703359A (da) |
CN (1) | CN1152316A (da) |
AT (1) | ATE195741T1 (da) |
AU (1) | AU688513B2 (da) |
BR (1) | BR9507663A (da) |
CA (1) | CA2190500A1 (da) |
CZ (1) | CZ338896A3 (da) |
DE (1) | DE69518515T2 (da) |
DK (1) | DK0759929T3 (da) |
ES (1) | ES2149365T3 (da) |
FI (1) | FI964610A0 (da) |
GR (1) | GR3034201T3 (da) |
HK (1) | HK1009274A1 (da) |
HU (1) | HU223613B1 (da) |
NZ (1) | NZ287230A (da) |
PT (1) | PT759929E (da) |
RO (1) | RO116550B1 (da) |
RU (1) | RU2149875C1 (da) |
SK (1) | SK282278B6 (da) |
WO (1) | WO1995032215A1 (da) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2160842T3 (es) * | 1995-10-23 | 2001-11-16 | Merck & Co Inc | Derivados de esteroides 17-alquil-4-aza-7-sustituidos. |
US5763361A (en) * | 1995-10-23 | 1998-06-09 | Merck & Co., Inc. | 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors |
US5872126A (en) * | 1996-09-06 | 1999-02-16 | Merck & Co., Inc. | Methods and compositions for treating preterm labor |
US6686486B1 (en) | 1997-05-07 | 2004-02-03 | Padma Marwah | Process for effecting allylic oxidation |
US5869709A (en) * | 1997-05-07 | 1999-02-09 | Humanetics Corporation | Process for effecting allylic oxidation |
US6252119B1 (en) * | 1997-07-28 | 2001-06-26 | Salvador Jorge Antonio Riberiro | Copper-catalysed allylic oxidation using alkyl hydroperoxide |
US6187925B1 (en) | 1997-12-23 | 2001-02-13 | Merck & Co., Inc. | Intermediates and process for the synthesis of azasteroids |
WO1999047485A1 (en) | 1998-03-18 | 1999-09-23 | Humanetics Corporation | Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents |
JP2002543216A (ja) | 1999-04-30 | 2002-12-17 | アーチ ディベロップメント コーポレイション | ステロイド誘導体 |
GB0020286D0 (en) * | 2000-08-18 | 2000-10-04 | Univ York | Cobalt catalysed allylic oxidation of unsaturated steroids using alkyl hydroperoxide |
US7078396B2 (en) * | 2001-05-03 | 2006-07-18 | Arch Development Corporation | Method of treating disorder related to high cholesterol concentration |
US20070197484A1 (en) * | 2001-05-03 | 2007-08-23 | Ching Song | Method of treating disorder related to high cholesterol concentration |
CA2446314C (en) * | 2001-05-03 | 2011-02-22 | The University Of Chicago | Liver x receptor agonists |
AU2003228485A1 (en) * | 2002-04-12 | 2003-10-27 | The University Of Chicago | Farnesoid x-activated receptor agonists |
US20070032464A1 (en) * | 2004-10-08 | 2007-02-08 | Shutsung Liao | Methods of treating cancers |
HUE052401T2 (hu) | 2005-03-10 | 2021-04-28 | Obagi Cosmeceuticals Llc | Stabil szerves peroxid-készítmények |
AU2006223251B2 (en) * | 2005-03-10 | 2011-08-25 | Jr Chem, Llc | Benzoyl peroxide compositions and methods of use |
US7556820B2 (en) | 2005-06-29 | 2009-07-07 | Jr Chem, Llc | Stable organic peroxide compositions |
US20090306023A1 (en) * | 2005-06-29 | 2009-12-10 | Ramirez Jose E | Stable organic peroxide compositions |
US20070044810A1 (en) * | 2005-06-29 | 2007-03-01 | Jr Chem, Llc | Method of enhanced drug application |
US20070001145A1 (en) * | 2005-06-29 | 2007-01-04 | Faryniarz Joseph R | Stable organic peroxide compositions |
CN101619089B (zh) * | 2009-07-28 | 2011-07-20 | 陈大刚 | 抗肿瘤药物cl168、其合成方法及应用 |
JP2013500986A (ja) * | 2009-07-29 | 2013-01-10 | ザ・ユニバーシティ・オブ・シカゴ | 肝臓x受容体アゴニスト |
WO2012105543A1 (ja) * | 2011-01-31 | 2012-08-09 | 旭化成ケミカルズ株式会社 | 混合液製造装置及び混合液調製方法 |
WO2013101719A2 (en) | 2011-12-27 | 2013-07-04 | Northeast Ohio Medical University | Amooranin compounds and analogs thereof and related methods of use |
AU2014233156A1 (en) * | 2013-03-15 | 2015-10-15 | Prevacus, Inc. | Synthesis of ent-progesterone and intermediates thereof |
CN103788163B (zh) * | 2014-01-27 | 2015-11-18 | 浙江大学 | 7-酮基甾类化合物的制备方法 |
AU2016361227B2 (en) | 2015-11-23 | 2021-06-10 | Biojiva Llc | Site-specific isotopic labeling of 1, 4-diene systems |
CN106008423B (zh) * | 2016-06-24 | 2018-02-02 | 云南民族大学 | 一种苯丙素类化合物及其制备方法和应用 |
AU2021224854A1 (en) | 2020-02-21 | 2022-10-06 | Biojiva Llc | Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8422443D0 (en) * | 1984-09-05 | 1984-10-10 | British Petroleum Co Plc | Oxidation of hydrocarbons |
DK173704B1 (da) | 1985-04-17 | 2001-07-09 | Hoffmann La Roche | Fremgangsmåde til katalytisk oxidation af allyliske grupper |
RU94046044A (ru) * | 1992-05-20 | 1996-10-10 | Мерк Энд Ко. | Новые 7 бета -замещенные 4-аза- 5 альфа -холестан-оны в качестве ингибиторов 5 альфа -редуктазы, фармацевтическая композиция на их основе, способ ее получения |
IL111467A0 (en) | 1993-11-12 | 1994-12-29 | Merck & Co Inc | Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors |
-
1995
- 1995-05-15 HU HU9603187A patent/HU223613B1/hu not_active IP Right Cessation
- 1995-05-15 US US08/718,408 patent/US6369247B1/en not_active Expired - Fee Related
- 1995-05-15 SK SK1478-96A patent/SK282278B6/sk unknown
- 1995-05-15 EP EP95920434A patent/EP0759929B1/en not_active Expired - Lifetime
- 1995-05-15 CZ CZ963388A patent/CZ338896A3/cs unknown
- 1995-05-15 AU AU25885/95A patent/AU688513B2/en not_active Ceased
- 1995-05-15 ES ES95920434T patent/ES2149365T3/es not_active Expired - Lifetime
- 1995-05-15 PT PT95920434T patent/PT759929E/pt unknown
- 1995-05-15 WO PCT/US1995/006004 patent/WO1995032215A1/en not_active Application Discontinuation
- 1995-05-15 KR KR1019960706509A patent/KR970703359A/ko not_active Abandoned
- 1995-05-15 NZ NZ287230A patent/NZ287230A/en unknown
- 1995-05-15 AT AT95920434T patent/ATE195741T1/de not_active IP Right Cessation
- 1995-05-15 RO RO96-02171A patent/RO116550B1/ro unknown
- 1995-05-15 CN CN95194043A patent/CN1152316A/zh active Pending
- 1995-05-15 DE DE69518515T patent/DE69518515T2/de not_active Expired - Fee Related
- 1995-05-15 JP JP7530344A patent/JPH10500682A/ja active Pending
- 1995-05-15 DK DK95920434T patent/DK0759929T3/da active
- 1995-05-15 BR BR9507663A patent/BR9507663A/pt not_active Application Discontinuation
- 1995-05-15 CA CA002190500A patent/CA2190500A1/en not_active Abandoned
- 1995-05-15 RU RU96124063/04A patent/RU2149875C1/ru not_active IP Right Cessation
-
1996
- 1996-11-18 FI FI964610A patent/FI964610A0/fi unknown
-
1998
- 1998-08-12 HK HK98109869A patent/HK1009274A1/xx not_active IP Right Cessation
-
2000
- 2000-08-24 GR GR20000401775T patent/GR3034201T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
FI964610L (fi) | 1996-11-18 |
EP0759929A1 (en) | 1997-03-05 |
HUT75778A (en) | 1997-05-28 |
EP0759929A4 (en) | 1998-09-30 |
JPH10500682A (ja) | 1998-01-20 |
SK282278B6 (sk) | 2002-01-07 |
KR970703359A (ko) | 1997-07-03 |
ATE195741T1 (de) | 2000-09-15 |
RU2149875C1 (ru) | 2000-05-27 |
FI964610A0 (fi) | 1996-11-18 |
SK147896A3 (en) | 1997-08-06 |
GR3034201T3 (en) | 2000-11-30 |
DE69518515T2 (de) | 2001-04-19 |
HU9603187D0 (en) | 1997-01-28 |
HU223613B1 (hu) | 2004-10-28 |
NZ287230A (en) | 1997-07-27 |
HK1009274A1 (en) | 1999-05-28 |
AU2588595A (en) | 1995-12-18 |
US6369247B1 (en) | 2002-04-09 |
ES2149365T3 (es) | 2000-11-01 |
RO116550B1 (ro) | 2001-03-30 |
CZ338896A3 (en) | 1997-07-16 |
WO1995032215A1 (en) | 1995-11-30 |
PT759929E (pt) | 2001-01-31 |
CA2190500A1 (en) | 1995-11-30 |
AU688513B2 (en) | 1998-03-12 |
DE69518515D1 (de) | 2000-09-28 |
BR9507663A (pt) | 1997-10-07 |
EP0759929B1 (en) | 2000-08-23 |
CN1152316A (zh) | 1997-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0759929T3 (da) | Oxidation af steroider, der har allylgrupper | |
ES2101942T3 (es) | Procedimiento de epoxidacion. | |
ES2028860T3 (es) | Catalizador para oxido de etileno y procedimiento para la produccion catalitica de oxido de etileno. | |
TR199801084T2 (xx) | Oksijenat d�n���m�nde ge�i� metali ihtiva eden k���k g�zenekli molek�ler elekli kataliz�rlerin kullan�m�. | |
DE59802965D1 (de) | Verfahren zur oxidation einer mindestens eine c-c-doppelbindung aufweisenden organischen verbindung | |
ATE357413T1 (de) | Katalysator und verfahren zur herstellung von wasserstoffperoxid | |
ES2150574T3 (es) | Separacion por membranas. | |
MX9206810A (es) | Catalizador de manganeso. | |
ATE401317T1 (de) | Ethylenoxid-katalysatoren | |
AR010027A1 (es) | Procedimiento de regeneracion de catalizadores del tipo de silicalita al titanio; utilizacion de dicho catalizador y procedimiento de sintesis deepoxidos en presencia de dicho catalizador | |
TW429163B (en) | Oxidazing catalyst system and an oxidation process by using the same | |
ES528559A0 (es) | Procedimiento para la depuracion de aguas residuales | |
ES479679A1 (es) | Un procedimiento de epoxidacion. | |
NO161848C (no) | Fremgangsmaate til fremstilling av hydrogenperoksyd. | |
ES463432A1 (es) | Procedimiento para mejorar la actividad de catalizadores portadores de plata usados. | |
MX157218A (es) | Produccion de etilen-glicol por la reaccion de metano,un peroxido organico y formaldehido | |
ES2057783T3 (es) | Procedimiento en dos etapas para endulzar una fraccion hidrocarbonada sulfurada. | |
ATE151431T1 (de) | Herstellung von n-phosphonomethylglysin und derensalze | |
DE60114663D1 (de) | Verfahren zur herstellung von organischen hydroperoxiden mit verringertem anteil an verunreinigungen | |
ATE111071T1 (de) | Verfahren zur herstellung von alkyltetrahydroanthrahydrochinonlösungen und ihre verwendung als arbeitslösung bei der wasserstoffperoxid-herstellung nach dem anthrachinonverfahren. | |
MX9605718A (es) | Oxidacion de esteroides que tienen grupos alilicos. | |
KR890012959A (ko) | 3-(2-히드로페록시-2-프로필)페놀 및 이를 이용한 레조르시놀의 제조 방법 | |
DK341283A (da) | Fremgangsmaade til oxidation af vinylbenzen-forbindelser til beta-phenylaldehyder | |
ATE98606T1 (de) | Rueckgewinnung von wasserstoffperoxid. | |
DE69734320D1 (de) | Aktivierter silber katalysator |